Publication | Open Access

Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors

Medicinal Chemistry-3-Trifluoromethyl-5-indolyl PyrazolinesPharmaceutical ScienceBiochemistryMedicineNatural SciencesPharmacological AgentPharmacotherapyBiological EvaluationAnti-cancer AgentDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery